[go: up one dir, main page]

MX2009011181A - Uso nuevo del hidroxitirosol. - Google Patents

Uso nuevo del hidroxitirosol.

Info

Publication number
MX2009011181A
MX2009011181A MX2009011181A MX2009011181A MX2009011181A MX 2009011181 A MX2009011181 A MX 2009011181A MX 2009011181 A MX2009011181 A MX 2009011181A MX 2009011181 A MX2009011181 A MX 2009011181A MX 2009011181 A MX2009011181 A MX 2009011181A
Authority
MX
Mexico
Prior art keywords
hydroxytyrosol
cartilage
novel use
regeneration
repair
Prior art date
Application number
MX2009011181A
Other languages
English (en)
Inventor
Daniel Raederstorff
Joseph Schwager
Karin Wertz
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of MX2009011181A publication Critical patent/MX2009011181A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se relaciona al uso de]. hidroxitirosol para la inducción o el aumento de la reparación del cartílago o regeneración del cartílago. Además, la invención se relaciona a las composiciones farmacéuticas y nutracéuticas que comprenden hidroxitirosol para la regeneración y reparación de lesiones de cartílago en las articulaciones, en particular de lesiones traumáticas de cartílago.
MX2009011181A 2007-04-18 2008-04-03 Uso nuevo del hidroxitirosol. MX2009011181A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07007872A EP1982706A1 (en) 2007-04-18 2007-04-18 Use of hydroxytyrosol for the treatment of cartilage injury
PCT/EP2008/002674 WO2008128629A1 (en) 2007-04-18 2008-04-03 Novel use of hydroxytyrosol

Publications (1)

Publication Number Publication Date
MX2009011181A true MX2009011181A (es) 2009-12-11

Family

ID=38435016

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011181A MX2009011181A (es) 2007-04-18 2008-04-03 Uso nuevo del hidroxitirosol.

Country Status (7)

Country Link
US (3) US20100113611A1 (es)
EP (2) EP1982706A1 (es)
JP (1) JP5793774B2 (es)
KR (2) KR20090130067A (es)
CN (1) CN101674817B (es)
MX (1) MX2009011181A (es)
WO (1) WO2008128629A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101435228B1 (ko) * 2006-07-14 2014-08-28 디에스엠 아이피 어셋츠 비.브이. 조성물, 및 염증성 질환의 치료, 병용-치료 또는 예방을 위한 이의 용도
KR20100045485A (ko) * 2007-08-21 2010-05-03 디에스엠 아이피 어셋츠 비.브이. 증류된 올리브 쥬스 추출물의 제조 방법
US20110014308A1 (en) * 2007-12-12 2011-01-20 Daniel Raederstorff Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders.
PL2418965T3 (pl) * 2009-04-17 2016-12-30 Połączenia hydroksytyrozolu do zwiększania czynności mitochondrium i wytwarzania energii
US8809311B2 (en) 2009-08-10 2014-08-19 Darlene McCord Nutritional supplements
CA2764060C (en) 2009-06-25 2015-08-25 Darlene Mccord Topical compositions and methods for wound care
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
ITMI20121092A1 (it) * 2012-06-21 2013-12-22 Zmg Nutraceutica S R L Formulazione anti-ossidante e anti-radicalica a base di sostanze di origine naturale ed integratori alimentari comprendenti tale composizione.
EP2925307B1 (en) 2012-11-30 2020-10-28 McCord, Darlene E. Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
ES2848552T3 (es) * 2013-04-05 2021-08-10 Nestle Sa Composiciones para estimular el crecimiento óseo
ES2944868T3 (es) * 2013-05-29 2023-06-26 Nestle Sa Oleuropeína para su uso en la degradación del cartílago
CN103961338B (zh) * 2014-04-03 2016-01-06 浙江大学 羟基酪醇在抗阿霉素心肌毒性中的应用及以羟基酪醇为主要活性成分的药物组合物
WO2016087428A1 (en) * 2014-12-04 2016-06-09 Dsm Ip Assets B.V. Fortification of edible oils with hyrdoxytyrosol
US9985112B2 (en) * 2015-02-06 2018-05-29 International Business Machines Corporation Sloped finFET with methods of forming same
AU2018365217B2 (en) * 2017-11-08 2024-02-15 Société des Produits Nestlé S.A. Homovanillyl alcohol (HVA), HVA isomer, methods of making compositions comprising such compounds, and methods using such compounds
WO2021251813A1 (es) * 2020-06-11 2021-12-16 Lopez Velarde Luna Jose Emmanuel Formulación de reemplazo/regeneración de colágeno y usos de la misma
JP2022096826A (ja) * 2020-12-18 2022-06-30 株式会社ノエビア 経口用組成物
JP2022124883A (ja) * 2021-02-16 2022-08-26 国立大学法人 香川大学 キノコの栽培方法、ポリフェノール類含有キノコおよびキノコ栽培用菌床
GR1010985B (el) * 2024-07-10 2025-06-24 ΑΝΩΝΥΜΗ ΓΑΛΑΚΤΟΚΟΜΙΚΗ ΒΙΟΜΗΧΑΝΙΚΗ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΥΙΟΙ Σ. ΜΠΑΦΑ με δ.τ. "ΥΙΟΙ Σ. ΜΠΑΦΑ Α.Β.Ε.Ε.", Παραγωγη λευκου τυριου εμπλουτισμενου με βιοφαινολες ελιας

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855908B1 (en) * 1995-12-11 2002-02-06 Omni Nutraceuticals, Inc. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
WO2002018310A1 (en) * 2000-09-01 2002-03-07 Creagri, Inc. Method of obtaining a hydroxytyrosol-rich composition from vegetation water
US8216599B2 (en) * 2002-02-13 2012-07-10 Creagri, Inc. Method for treatment of inflammation
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
JP2004141130A (ja) * 2002-08-28 2004-05-20 Mars Inc 特定の犬種に専用のドッグフード
JP2004091642A (ja) * 2002-08-30 2004-03-25 Fujikura Ltd シリコーン樹脂組成物およびこれを用いた電線・ケーブル
JP2004026846A (ja) * 2003-09-09 2004-01-29 Rohto Pharmaceut Co Ltd 関節痛治療または予防用組成物
JP2005154281A (ja) * 2003-11-20 2005-06-16 Ominedo Yakuhin Kogyo Kk 関節障害予防及び治療用医薬組成物
US20050176674A1 (en) * 2004-02-09 2005-08-11 Friesen Kim G. Composition and method for use in cartilage affecting conditions
JP2008509224A (ja) * 2004-08-09 2008-03-27 クレアグリ， インコーポレイテッド 炎症状態を治療するためのオリーブ組成物及び方法
ES2702047T3 (es) * 2004-11-16 2019-02-27 Dsm Ip Assets Bv Uso de compuestos antioxidantes para el daño muscular
JP2006290812A (ja) * 2005-04-12 2006-10-26 Rohto Pharmaceut Co Ltd 鎮痛製剤
JP5175481B2 (ja) * 2006-10-23 2013-04-03 エーザイフード・ケミカル株式会社 軟骨再生促進剤

Also Published As

Publication number Publication date
EP1982706A1 (en) 2008-10-22
US20130005682A1 (en) 2013-01-03
WO2008128629A1 (en) 2008-10-30
EP2134331A1 (en) 2009-12-23
KR20090130067A (ko) 2009-12-17
JP5793774B2 (ja) 2015-10-14
CN101674817A (zh) 2010-03-17
US20100113611A1 (en) 2010-05-06
KR20150056664A (ko) 2015-05-26
CN101674817B (zh) 2012-12-26
JP2010524867A (ja) 2010-07-22
US20160136108A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
MX2009011181A (es) Uso nuevo del hidroxitirosol.
UY32728A (es) Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
CY1118691T1 (el) Συνθεσεις και μεθοδοι χρησης για αντισωματα κατα σκληροστινης
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
CL2011000301A1 (es) Compuestos derivados de purina con actividad inmunomoduladora; composición farmacéutica que los comprende; y uso de ellos en el tratamiento de enfermedades alérgicas, rinitis alérgica, asma, enfermedades infecciosas y cáncer.
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
CL2008002006A1 (es) Compuestos derivados de morfolin pirimidina, composicion farmaceutica, y su uso como inhibidores de la m-tor-quinasa para el tratamiento de l a inflamacion, cancer, enfermedades inmunes, enfermedad obstructiva pulmonar, enfermedad cardiovascular.
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
GT201400111A (es) Triazolopiridinas sustituidas
CR20110100A (es) Nuevos derivados de sulfamida sustituida
BR112012004420A2 (pt) "composição com alto teor proteico para a indústria alimentícia"
BRPI0815821A2 (pt) Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
BRPI1010617A2 (pt) uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição.
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
BRPI0812022A2 (pt) Composições para produção de soja com teor de óleo elevado.
SV2011003827A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
BRPI0819104A2 (pt) Aço para haste de conexão do tipo divisão por fratura

Legal Events

Date Code Title Description
FG Grant or registration